Chronic kidney disease (CKD) is associated with high risk for cardiovascular disease (CVD).
This association is multifactorial, but CKD is often associated with dyslipidemia, which likely …

Dysregulation in lipid metabolism is the leading cause of chronic kidney disease (CKD) and
also the important risk factors for high morbidity and mortality. Although lipid abnormalities …

Chronic kidney disease (CKD) results in significant dyslipidemia and profound changes in
lipid and lipoprotein metabolism. The associated dyslipidemia, in turn, contributes to …

Although hemodialysis treatment has greatly increased the life expectancy of end stage
renal disease patients, low quality of life among hemodialysis patients is frequently reported …

Since plasma lipoproteins contain both protein and phospholipid components, either may be
involved in processes such as atherosclerosis. In this study the identification of plasma …

Alisma orientale Juzepzuk (AO) is widely used for various diuretic and nephropathic
treatments in traditional Chinese medicines (TCM). In a clinical setting, AO is used as both a …

This study compared the molecular lipidomic profile of LDL in patients with nondiabetic
advanced renal disease and no evidence of CVD to that of age-matched controls, with the …

Diabetic kidney disease, diagnosed by urinary albumin excretion rate (AER), is a critical
symptom of chronic vascular injury in diabetes, and is associated with dyslipidemia and …

Dyslipoproteinemia and oxidative modification of low-density lipoprotein (oxLDL) contribute
to the development of oxidative stress and atherosclerosis in chronic kidney disease (CKD) …

Aim: Chronic kidney disease (CKD) may lead to reduced concentrations of high-density
lipoprotein (HDL) and its subfractions (HDL2 and HDL3), and damage them via …